Skip to content

An attention bias modification training as waitlist intervention for depression: A randomized controlled trial

An attention bias modification training as waitlist intervention for depression: A randomized controlled trial - Attention bias modification in depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40250
Enrollment
120
Registered
2014-06-18
Start date
2014-10-02
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depressive disorder major depressive disorder

Interventions

A computerized positivity training, based on cognitive bias modification (CBM) for attention, is offered eight times during a period of two weeks (i.e., 4 weekly sessions), for 25 minutes per sessio

Sponsors

ProPersona (Nijmegen)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - A diagnosis of major depressive disorder, first or recurrent according to the DSM- IV-TR, as assessed with the MINI. - Wait-listed for Cognitive Behavioral Therapy - Age: between 21-65 years

Exclusion criteria

Exclusion criteria: - Any psychotic disorder (current or previous) - Current mania or hypomania or a history of bipolar disorder - Cognitive disabilities (IQ

Design outcomes

Primary

MeasureTime frame
Primary study parameter is a change in attentional bias as assessed by the *dot probe task*.

Secondary

MeasureTime frame
Next to investigating training effect on changes in bias, understanding the impact of the intervention on depressive symptomatology, emotional vulnerability and quality of life is important from a clinical perspective, while assessing the cost-effectiveness is important from a societal perspective. For these secondary (i.e., more distal) outcomes, a probabilistic medical decision-making approach is taken. Secondary outcome measures are emotional vulnerability in response to a speech task and a decrease in depressive symptoms. Other secondary outcome measures are a change in attentional bias for verbal positive and negative information (*emotional Stroop task*), a change in positive imagery abilities, attentional control, ruminative thinking, resilience, positive and negative affect, memory bias, number of sessions of usual care, and quality of life and costs and diagnostic status at 12 months follow-up.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)